NCT06004167View on ClinicalTrials.gov

Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T)

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 14, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

December 1, 2024

Conditions
Lymphoma, B-CellRelapsed CancerRefractory LymphomaDiffuse Large B Cell LymphomaMediastinal Large B-cell LymphomaHigh-grade B-cell LymphomaFollicular LymphomaMantle Cell Lymphoma
Interventions
RADIATION

Adaptive Bridging Radiation Therapy (ABRT)

Radiation Therapy

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

Sponsors

Collaborators (1)

Varian Medical Systems
All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

collaborator

Varian Medical Systems

INDUSTRY